Scientific Reports (Aug 2022)

Antiviral effect of cetylpyridinium chloride in mouthwash on SARS-CoV-2

  • Ryo Takeda,
  • Hirofumi Sawa,
  • Michihito Sasaki,
  • Yasuko Orba,
  • Nako Maishi,
  • Takuya Tsumita,
  • Natsumi Ushijima,
  • Yasuhiro Hida,
  • Hidehiko Sano,
  • Yoshimasa Kitagawa,
  • Kyoko Hida

DOI
https://doi.org/10.1038/s41598-022-18367-6
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 8

Abstract

Read online

Abstract Cetylpyridinium chloride (CPC), a quaternary ammonium compound, which is present in mouthwash, is effective against bacteria, fungi, and enveloped viruses. This study was conducted to explore the antiviral effect of CPC on SARS-CoV-2. There are few reports on the effect of CPC against wild-type SARS-CoV-2 at low concentrations such as 0.001%–0.005% (10–50 µg/mL). Interestingly, we found that low concentrations of CPC suppressed the infectivity of human isolated SARS-CoV-2 strains (Wuhan, Alpha, Beta, and Gamma) even in saliva. Furthermore, we demonstrated that CPC shows anti-SARS-CoV-2 effects without disrupting the virus envelope, using sucrose density analysis and electron microscopic examination. In conclusion, this study provided experimental evidence that CPC may inhibit SARS-CoV-2 infection even at lower concentrations.